FrancophonIA/ELRC3.0 huggingface dataset:
English: When angiotensin II antagonists are administered simultaneously with non-steroidal antiinflammatory medicinal products (i.e. selective COX-2 inhibitors, acetylsalicylic acid (> 3 g/day) and non-selective NSAIDs), attenuation of the antihypertensive effect may occur.
Danish: Når angiotensin II-antagonister administreres samtidig med non-steroide anti-inflammatoriske lægemidler (fx selektive COX 2-hæmmere, acetylsalicylsyre (> 3 g/dag) og nonselektive NSAID) kan den antihypertensive virkning svækkes.
English: Marketing Authorisation Holder and Manufacturer KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Danish: Indehaveren af markedsføringstilladelsen og fremstiller KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenien
English: As observed for angiotensin converting enzyme inhibitors, irbesartan and the other angiotensin antagonists are apparently less effective in lowering blood pressure in black people than in non-blacks, possibly because of higher prevalence of low-renin states in the black hypertensive population (see section 5.1).
Danish: Som det også er observeret for angiotensin-konverterende enzymhæmmere er irbesartan og de andre angiotensin antagonister tilsyneladende mindre effektive til at nedsætte blodtrykket hos sorte patienter end hos hvide, muligvis fordi reninniveauet ofte er lavere hos den sorte hypertensive befolkning (se pkt.
English: Approximately 33% of patients in the irbesartan group reached the primary renal composite endpoint compared to 39% and 41% in the placebo and amlodipine groups [20% relative risk reduction versus placebo (p = 0.024) and 23% relative risk reduction compared to amlodipine (p = 0.006)].
Danish: Ca. 33% af patienterne i irbesartangruppen nåede det primære kombinerede nyreendepunkt sammenlignet med henholdsvis 39% og 41% i placebo- og amlodipin-gruppen (20% relativ risikoreduktion versus placebo (p= 0,024) og 23% relativ risiko reduktion sammenlignet med amlodipin (p= 0,006).
English: The most likely manifestations of overdosage are expected to be hypotension and tachycardia; bradycardia might also occur from overdose.
Danish: De mest sandsynlige tegn på overdosering forventes at være hypotension og takykardi.
English: Additional antihypertensive agents (excluding ACE inhibitors, angiotensin II receptor antagonists and dihydropyridine calcium blockers) were added as needed to help achieve the blood pressure goal.
Danish: Yderligere antihypertensive præparater (eksklusiv ACE-hæmemer, angiotensin II-receptorantagonister og dihydropyridin-calciumblokkere) blev tilføjet efter behov for at nå blodtryksmålet.
English: Based on its pharmacodynamic properties, irbesartan is unlikely to affect the ability to drive and use machines.
Danish: På baggrund af de farmakodynamiske egenskaber er det dog usandsynligt, at irbesartan vil påvirke evnen til at føre motorkøretøj eller betjene maskiner.
English: Close monitoring of serum potassium in patients at risk is recommended (see section 4.5).
Danish: Der anbefales tæt kontrol af serumkalium hos patienter, der tilhører en risikogruppe (se pkt.
English: Do not take Ifirmasta - if you are allergic to irbesartan or any of the other ingredients of this medicine (listed in section 6), - if you are more than 3 months pregnant.
Danish: Tag ikke Ifirmasta: - hvis De er allergisk over for irbesartan eller et af de øvrige indholdsstoffer i Ifirmasta (angivet i afsnit 6).
English: When irbesartan is administered concomitantly with a low dose of hydrochlorothiazide (e.g. 12.5 mg daily), the antihypertensive response in black patients approaches that of white patients.
Danish: Når irbesartan administreres samtidig med en lille dosis hydrochlorthiazid (fx 12,5 mg daglig) nærmer det antihypertensive respons hos sorte sig det, der forekommer hos hvide patienter.
English: In patients with high blood pressure and type 2 diabetes with renal disease, dizziness when getting up from a lying or sitting position, low blood pressure when getting up from a lying or sitting position, pain in joints or muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also reported.
Danish: Hos patienter med forhøjet blodtryk og type 2diabetes med nyresygdom, blev der også indberettet svimmelhed når man rejser sig op fra liggende eller siddende stilling, lavt blodtryk når man rejser sig op fra liggende eller siddende stilling, led- og muskelsmerter og en nedsat mængde protein i de røde blodlegemer (hæmoglobin).
English: Aliskiren-containing products or ACE-inhibitors:
Danish: Aliskiren-holdige lægemidler eller ACE-hæmmere:
English: Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired renal function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis) and severe allergic reactions (anaphylactic shock).
Danish: Bivirkninger, hvor hyppigheden ikke er kendt: følelse af, at omgivelserne kører rundt, hovedpine, smagsforstyrrelser, ringen for ørerne, muskelkramper, led- og muskelsmerter, nedsat antal blodplader, unormal leverfunktion, forhøjet mængde af kalium i blodet, nedsat nyrefunktion, betændelseslignende tilstand i de små blodkar, der primært påvirker huden (en tilstand der kaldes leukocytoklastisk vaskulitis) samt alvorlige allergiske reaktioner (anafylaktisk shock).
English: If you get any of these symptoms or get short of breath, stop taking irbesartan and contact your doctor immediately.
Danish: Hvis du får et eller flere af disse symptomer eller hvis du får åndenød, skal du holde op med at tage irbesartan og straks søge lægehjælp.
English: As with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalemia may occur during the treatment with Ifirmasta, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Danish: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteronsystemet, kan der opstå hyperkaliæmi under behandling med Ifirmasta, specielt i tilfælde af nyrefunktionsnedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom, og/eller hjertefejl.
English: The following table presents the adverse medicinal product reactions that were reported in placebocontrolled trials in which 1,965 hypertensive patients received irbesartan.
Danish: Følgende tabel viser bivirkninger indberettet i placebokontrollerede forsøg, hvor 1965 hypertensive patienter har modtaget irbesartan.
English: - if you are taking any of the following medicines used to treat high blood pressure: - an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems, - aliskiren.
Danish: - hvis du skal opereres eller bedøves - hvis du samtidig tager et af følgende lægemidler til behandling af for højt blodtryk: - en ACE-hæmmer (f.eks. enalapril, lisinopril, ramipril), især hvis du har nyrerproblemer i forbindelse med sukkersyge - aliskiren
English: Patients in all treatment groups typically received between 2 and 4 antihypertensive agents (e.g., diuretics, beta blockers, alpha blockers) to reach a predefined blood pressure goal of ≤ 135/85 mmHg or a 10 mmHg reduction in systolic pressure if baseline was > 160 mmHg.
Danish: I samtlige af behandlingsgrupperne fik patienterne typisk mellem 2 og 4 antihypertensive lægemidler (f.eks. diuretikum, betablokkere, alfablokkere) for at opnå en foruddefineret blodtryksværdi på ≤ 135/85 mmHg eller en 10 mmHg reduktion i systolisk tryk, hvis baseline var > 160 mmHg.
English: The pharmacokinetics of irbesartan were evaluated in 23 hypertensive children after the administration of single and multiple daily doses of irbesartan (2 mg/kg) up to a maximum daily dose of 150 mg for four weeks.
Danish: Irbesartans farmakokinetik evalueredes hos 23 hypertensive børn efter administration af enkeltdosis irbesartan og gentagne doser irbesartan (2 mg/kg) i doser på op til maksimalt 150 mg daglig i 4 uger.
English: - Very common (may affect more than 1 in 10 people): if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Danish: - Meget almindelig (kan påvirke flere end 1 ud af 10 patienter): hvis du har højt blodtryk og type 2 diabetes med nyresygdom, kan blodprøver vise, at du har for meget kalium i blodet.
English: thrombocytopenia
Danish: Trombocytopeni
English: - Common (may affect up to 1 in 10 people): dizziness, feeling sick/vomiting, and fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Danish: - Almindelig (kan påvirke op til 1 ud af 10 patienter): Svimmelhed, utilpashed/opkastning, træthed og blodprøver, der viser en forhøjet mængde af et enzym, der måler muskel- og hjertefunktionen (kreatinin-kinase-enzym).
English: In patients whose vascular tone and renal function depend predominantly on the activity of the reninangiotensin-aldosterone system (e.g. patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with angiotensin converting enzyme inhibitors or angiotensin-II receptor antagonists that affect this system has been associated with acute hypotension, azotaemia, oliguria, or rarely acute renal failure (see section 4.5).
Danish: Hos patienter, hvis vaskulære tonus og nyrefunktion hovedsageligt afhænger af renin-angiotensinaldosteronsystemets aktivitet, (fx patienter med alvorlig hjerteinsufficiens eller underliggende nyresygdom, inklusive nyrearteriestenose), er behandling med angiotensinkonverterende enzymhæmmere eller angiotensin-II receptorantagonister, der påvirker dette system, blevet forbundet med akut hypotension, azotæmi, oliguri og i sjældne tilfælde med akut nyresvigt (se pkt.
English: C irbesartan, 80-85% of the circulating plasma radioactivity is attributable to unchanged irbesartan.
Danish: Efter oral eller intravenøs administration af 14C irbesartan, kan 80-85% af den cirkulerende radioaktivitet i plasma tilskrives uomdannet irbesartan.
English: 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 56x1 film-coated tablets 84 film-coated tablets 90 film-coated tablets 98 film-coated tablets
Danish: 14 filmovertrukne tabletter 28 filmovertrukne tabletter 30 filmovertrukne tabletter 56 filmovertrukne tabletter 56 x 1 filmovertrukne tabletter 84 filmovertrukne tabletter 90 filmovertrukne tabletter 98 filmovertrukne tabletter
English: Ifirmasta slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Danish: Ifirmasta mindsker faldende nyrefunktion hos patienter med forhøjet blodtryk og type 2- diabetes (sukkersyge).
English: Diabetes Mellitus (IRMA 2)” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria.
Danish: IRMA 2-studiet (Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2diabetes mellitus) viste, at irbesartan 300 mg forsinker progression til klinisk proteinuri hos patienter med mikroalbuminuri.
English: The concomitant use of Ifirmasta with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Danish: Samtidig brug af Ifirmasta og lægemidler indeholdende aliskiren er kontraindiceret hos patienter med diabetes mellitus eller nedsat nyrefunktion (GFR < 60 ml/min/1,73 m2) (se pkt.
English: Reduction of blood pressure with 0.5 mg/kg (low), 1.5 mg/kg (medium) and 4.5 mg/kg (high) target titrated doses of irbesartan was evaluated in 318 hypertensive or at risk (diabetic, family history of hypertension) children and adolescents aged 6 to 16 years over a three week period.
Danish: Reduktion af blodtryk med 0,5 mg/kg (lav), 1,5 mg/kg (middel) og 4,5 mg/kg (høj) mål-titrerede doser af irbesartan evalueredes, over en periode på 3 uger, hos 318 børn og unge med hypertension eller i risiko for at udvikle hypertension (diabetes, familiær disposition for hypertension) i aldersgruppen 6 til 16 år.
English: Potassium supplements and potassium-sparing diuretics:
Danish: Kaliumtilskud og kalium-besparende diuretika:
English: Blood and lymphatic system disorders: Not known:
Danish: Blod og lymfesystem Ikke kendt:
English: Exposure to AIIRA therapy during the second and third trimesters is known to induce human foetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia).
Danish: Det er kendt, at eksponering for behandling med AIIRAer under andet og tredje trimester kan inducere human føtotoksicitet (nedsat nyrefunktion, oligohydramnios, hæmning af kraniets ossifikation) og neonatal toksicitet (nyresvigt, hypotension, hyperkaliæmi) (se pkt.
English: - Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.
Danish: - Ikke almindelig (kan påvirke op til 1 ud af 100 patienter): Hurtig hjerterytme, rødme, hoste, diarré, fordøjelsesbesvær/halsbrand, seksuelle problemer, brystsmerter.
English: Ear and labyrinth disorder: Not known:
Danish: Øre og labyrint: Ikke kendt:
English: In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/day and serum creatinine ranging from 1.0-3.0 mg/dl, the long-term effects (mean 2.6 years) of irbesartan on the progression of renal disease and all-cause mortality were examined.
Danish: Hos 1715 hypertensive patienter med type 2-diabetes, proteinuri ≥ 900 mg/dag og serumkreatininværdier i intervallet 1,0-3,0 mg/dl, evalueredes langtidseffekterne (median 2,6 år) ved irbesartan med henblik på progression af nyresygdom og total mortalitet.
English: In clinical studies, the pharmacokinetic of irbesartan is not affected by hydrochlorothiazide.
Danish: Irbesartans farmakokinetik er i kliniske forsøg ikke påvirket af hydrochlorthiazid.
English: Because no information is available regarding the use of Ifirmasta during breast-feeding, Ifirmasta is not recommended and alternative treatments with better established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm infant.
Danish: Da der ikke foreligger oplysninger om anvendelse af Ifirmasta under amning, frarådes brugen af Ifirmasta, og andre behandlingsregimer med en mere veletableret sikkerhedsprofil for anvendelse under amning bør foretrækkes.
English: Always take this medicine exactly as your doctor or pharmacist has told you.
Danish: Tag altid Ifirmasta nøjagtigt efter lægen eller apotekspersonalets anvisning.
English: How to take Ifirmasta
Danish: Sådan skal De tage Ifirmasta
English: C irbesartan, about 20% of the radioactivity is recovered in the urine, and the remainder in the faeces.
Danish: Efter enten peroral eller intravenøs administration af 14C irbesartan, genfindes ca. 20% radioaktivitet i urinen og resten i afføringen.
English: In patients insufficiently controlled with 150 mg once daily, the dose of Ifirmasta can be increased to 300 mg, or other antihypertensive agents can be added (see sections 4.3, 4.4, 4.5 and 5.1).
Danish: Hos patienter som ikke er tilstrækkeligt kontrolleret på 150 mg, 1 gang dagligt, kan dosis af Ifirmasta øges til 300 mg, eller andre antihypertensiva kan tilføjes (se pkt.
English: Hypertensive patients with type 2 diabetes and renal disease The effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Danish: Hypertensive patienter med type 2-diabetes og nefropati I en undersøgelse med patienter med fremskreden nyresygdom var effekten af irbesartan på nyrer og kardiovaskulære hændelser ikke den samme i alle sub-grupper.
English: Once daily dosing with 150 mg produced trough and mean 24 hour responses similar to twice daily dosing on the same total dose.
Danish: 150 mg,1 gang dagligt, gav minimums- og gennemsnitlig 24 timers respons svarende til samme døgndosis givet 2 gange dagligt.
English: Respiratory, thoracic and mediastinal disorders: Uncommon: cough
Danish: Luftveje, thorax og mediastinum: Ikke almindelig:
English: Some undesirable effects have been reported since marketing of irbesartan.
Danish: Der er indberettet bivirkninger efter markedsføring af Ifirmasta.
English: CARTON FOLDING BOX
Danish: KARTON ÆSKE
English: Based on experience with the use of other medicinal products that affect the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e.g. heparin) may lead to increases in serum potassium and is, therefore, not recommended (see section 4.4).
Danish: Erfaringer med brug af andre lægemidler, der indvirker på renin-angiotensinsystemet, viser at samtidig brug af kalium-besparende diuretika, kaliumtilskud, kaliumholdige salterstatninger eller andre lægemidler, som kan øge serumkaliumniveauet (fx heparin), kan medføre øget serum-kalium.
English: Ifirmasta 75 mg film-coated tablets Ifirmasta 150 mg film-coated tablets Ifirmasta 300 mg film-coated tablets
Danish: Ifirmasta 75 mg filmovertrukne tabletter Ifirmasta 150 mg filmovertrukne tabletter Ifirmasta 300 mg filmovertrukne tabletter
English: Ifirmasta 150 mg film-coated tablets 14 tablets: EU/1/08/480/007
Danish: Ifirmasta 150 mg filmovertrukne tabletter 14 tabletter: EU/1/08/480/007
English: The dose may later be increased to 300 mg once daily depending on blood pressure response.
Danish: Dosis kan senere øges til 300 mg 1 gang dagligt i henhold til blodtryksmålingerne.
English: Ifirmasta 300 mg film-coated tablets 14 tablets: EU/1/08/480/013
Danish: Ifirmasta 300 mg filmovertrukne tabletter 14 tabletter: EU/1/08/480/013
English: As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function.
Danish: Som det er tilfældet med ACE-hæmmere, kan samtidig anvendelse af angiotensin II-antagonister og NSAID medføre øget risiko for forværring af nyrefunktionen herunder muligt akut nyresvigt samt øgning af serum-kalium.
English: The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. Doses of 150-300 mg once daily lower supine or seated blood pressures at trough (i.e. 24 hours after dosing) by an average of 8-13/5-8 mm Hg (systolic/diastolic) greater than those associated with placebo.
Danish: Doser på 150300 mg, 1 gang daglig, giver en sænkning af det liggende eller siddende blodtryk i minimumpunktet (dvs. 24 timer efter dosering), som i gennemsnit er 8-13/5-8 mmHg (systolisk/diastolisk) større end ved placebo-behandling.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med Ifirmasta Fortæl det altid til lægen eller apoteket, hvis du bruger anden medicin eller har brugt det for nylig.
English: Reproductive system and breast disorders: Uncommon: sexual dysfunction
Danish: Det reproduktive system og mammae: Ikke almindelig:
English: Vascular disorders: Common:
Danish: Vaskulære sygdomme: Almindelig:
English: In 1.7% of hypertensive patients with advanced diabetic renal disease treated with irbesartan, a decrease in haemoglobin*, which was not clinically significant, has been observed.
Danish: Der er set fald i hæmoglobin*, som ikke var klinisk signifikant, hos 1,7% af de hypertensive patienter med fremskreden diabetisk nyresygdom behandlet med irbesartan.
English: The demonstration of renal benefit of Ifirmasta in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Danish: Dokumentationen for forbedring af nyresygdom ved brug af Ifirmasta hos hypertensive type 2diabetikere er baseret på studier, hvor irbesartan blev brugt efter behov med tillæg af andre antihypertensive lægemidler for at nå det ønskede blodtryk (se pkt.
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function, - if you are going to have an operation (surgery) or be given anaesthetics,
Danish: I dette tilfælde kan lægen tage regelmæssige blodprøver med særlig henblik på at måle kaliumniveauet i blodet, hvis nyrefunktionen er nedsat
English: The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response.
Danish: Dosis kan senere øges til 300 mg 1 gang dagligt (fire tabletter dagligt) i henhold til blodtryksmålingerne.
English: The dose may later be increased to 300 mg (two tablets a day) once daily depending on blood pressure response.
Danish: Dosis kan senere øges til 300 mg 1 gang dagligt (to tabletter dagligt) i henhold til blodtryksmålingerne.
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure).
Danish: Der er tegn på, at samtidig brug af ACE-hæmmere og angiotensin II-receptorantagonister eller aliskiren øger risikoen for hypotension, hyperkaliæmi og nedsat nyrefunktion (inklusive akut nyresvigt).
English: hyperkalaemia
Danish: Hyperkaliæmi
English: Special Populations
Danish: Ældre personer
English: - This medicine has been prescribed for you only.
Danish: - Lægen har ordineret Ifirmasta til Dem personligt.
English: Ifirmasta 75 mg film-coated tablets
Danish: Ifirmasta 75 mg filmovertrukne tabletter
English: Ifirmasta 75 mg film-coated tablets Each film-coated tablet contains 75 mg irbesartan (as hydrochloride).
Danish: Ifirmasta 75 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 75 mg irbesartan (som hydrochlorid).
English: What Ifirmasta looks like and contents of the pack Ifirmasta 75 mg film-coated tablets are: white, oval film-coated tablets.
Danish: Udseende og pakningsstørrelse Ifirmasta 75 mg filmovertrukne tabletter er: hvide, ovale filmovertrukne tabletter.
English: Ifirmasta 300 mg film-coated tablets Irbesartan
Danish: Ifirmasta 300 mg filmovertrukne tabletter Irbesartan
English: Ifirmasta 300 mg film-coated tablets Each film-coated tablet contains 300 mg irbesartan (as hydrochloride).
Danish: Ifirmasta 300 mg filmovertrukne tabletter Hver filmovertrukken tablet indeholder 300 mg irbesartan (som hydrochlorid).
English: What Ifirmasta looks like and contents of the pack Ifirmasta 300 mg film-coated tablets are: white, oval film-coated tablets.
Danish: Udseende og pakningsstørrelse Ifirmasta 300 mg filmovertrukne tabletter er: hvide, ovale filmovertrukne tabletter.
English: Ifirmasta 150 mg film-coated tablets are available in boxes of 14, 28, 30, 56, 84, 90 and 98 film-coated tablets in blisters and in boxes of 56 x 1 film-coated tablets in perforated unit dose blisters.
Danish: Ifirmasta 150 mg filmovertrukne tabletter: leveres i æsker af 14, 28, 30, 56, 84, 90 og 98 filmovertrukne tabletter i blisterkort samt i æsker á 56 x 1 filmovertrukne tabletter i perforerede enkeltdosis-blisterkort.
English: Ifirmasta 75 mg film-coated tablets Irbesartan
Danish: Ifirmasta 75 mg filmovertrukne tabletter Irbesartan
English: Other antihypertensive agents may increase the hypotensive effects of irbesartan; however Ifirmasta has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Danish: På trods af dette er Ifirmasta uden risiko blevet administreret sammen med andre antihypertensive lægemidler som betablokkere, langtidsvirkende calcium-antagonister samt diuretika af thiazidtypen.